IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Johnson Matthey to Close Prostaglandin API Facility in Ireland

11:18 AM MDT | April 10, 2009 | DEEPTI RAMESH

Johnson Matthey says it plans to close its prostaglandin active pharmaceutical ingredient (API) facility at Cork, Ireland with the loss of 21 jobs, due to poor demand in the European market. The company says it plans to consolidate manufacturing of prostaglandin products at its U.S. facility at Devens, MA. Johnson Matthey inherited the facility when it acquired Cascade Biochem (Cork), a manufacturer and supplier of prostaglandins and other complex molecules as APIs, in 2002. “Johnson Matthey acquired Cascade Biochem and its prostaglandin API site with a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa